RPCEC00000097尚未招募3 期
CLINICAL TRIAL PHASE III Efficacy of the Glicigen – Viusid in the treatment of external genitals anus wart in children
Catálysis S.L.0 个研究点开始时间: 2010年9月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 6 years 至 18 years（—）
- 性别
- All
入选标准
- •Patient with lesions characteristic and diagnostic of (externalanus genitals warts) To be included beetwen 6 and 18 years old of both sexes.(Identify Card) Signed informed consent Negative VDRL, Hepatitis B Antigen and HIV diagnostic test
排除标准
- •With previous treatment Pregnant Patients taking steroides, inmunomodulates and topic and sistemic antivirals therapy Patient that refer manifestations of high sensibility to the medication
研究者
相似试验
进行中（未招募）
1 期
Clinical study phase III evaluating the efficacy of Diffusil H Forte sprayEUCTR2007-002478-76-CZybar a.s.110
进行中（未招募）
3 期
A Phase III clinical study of LF111 in Japanese women desiring contraceptioJPRN-jRCT2031210556Kikuyama Ryoko260
进行中（未招募）
不适用
A Phase III trial evaluating the tolerability of Grazax treatment in combination with antihistamine in subjects with seasonal grass pollen induced rhinoconjunctivitisGrass pollen induced rhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039097Term: RhinoconjunctivitisEUCTR2008-003593-18-DEALK-Abelló A/S
进行中（未招募）
3 期
A phase III clinical study in patients with active rheumatoid arthritis who show an inadequate response or intolerance to previous or current treatmentRheumatoid ArthritisJPRN-jRCT2011220026Okugaito Izumi113
进行中（未招募）
不适用
A Phase III Clinical Trial to Evaluate the Efficacy, Immunogenicity, Safety and Tolerability of ZOSTAVAX™ in Subjects 50 to 59 Years of Age - ZOSTAVAX™ in Subjects 50 to 59 Years of AgeMedDRA version: 9.1Level: LLTClassification code 10019974Term: Herpes zosterHerpes ZosterEUCTR2007-004020-20-FIMSD Finland20,300